Following up on the recent researches in India, stem cell therapy could be a ray of light for patients and their families who are trying to find a cure for diabetes and autism. Stem cell treatment has been widely investigated and used in China and Japan but due to lack of autism awareness, many people don’t even think about this therapy as a treatment option.
Scientists are pretty sure that the umbilical cord tissue-derived mesenchymal stem cells are ideal for treating incurable diseases like autism, diabetes Type 1 and other, because they allow doctors to administer uniform doses. They don’t need a collection of stem cells from the patient considering it could be a laborious process for child and the parent. Because they are collected right after birth, umbilical cord-derived cells are much more potent than their “older” counterparts like bone marrow-derived cells.
According to Cell Medicine “The rationable behind this treatment is that autism has been significantly correlated inflammatory and neuro-inflammatory cytokines including macrophage-derived chemokine (MDC) and thymus and activation-regulated chemokine (TARC). Intravenous administration of umbilical cord MSCs has been shown in multiple clinical trials to decrease inflammation. Decreasing inflammation in the autistic patient may alleviate symptoms of autism.”